NHI causes uncertainty for medical schemes
NHI causes uncertainty with its ambitious goals in South Africa. Analyse the challenges to health financing reforms and public funding.
NHI causes uncertainty with its ambitious goals in South Africa. Analyse the challenges to health financing reforms and public funding.
Adcock Ingram's Urizone receives legal protection as the court halts Cipla's Furizome, citing trademark infringement.
Pharma giants push EU to revise drug pricing policies, seeking higher prices to bolster investment and innovation in Europe.
Explore the Aspen Pharmacare manufacturing dispute and its potential impact on core earnings for the 2025 financial year.
Health Minister Aaron Motsoaledi discusses the NHI advertising campaign designed to address misinformation and support health efforts.